[{"Assets_0_Q1_USD":11639600000.0,"CommonStockSharesOutstanding_0_Q1_shares":139700000.0,"EarningsPerShareBasic_1_Q1_USD":0.57,"EarningsPerShareDiluted_1_Q1_USD":0.57,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":172400000.0,"NetIncomeLoss_1_Q1_USD":80800000.0,"StockholdersEquity_0_Q1_USD":6205400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":141400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":140800000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180508"}]